ID
37308
Description
Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1); ODM derived from: https://clinicaltrials.gov/show/NCT02227862
Link
https://clinicaltrials.gov/show/NCT02227862
Keywords
Versions (1)
- 7/15/19 7/15/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
July 15, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Type 1 Diabetes NCT02227862
Eligibility Type 1 Diabetes NCT02227862
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Hypersensitivity Insulin Ingredient | Hypersensitivity Insulin Analogue Ingredient | Drug Allergy
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0021641
- UMLS CUI [1,3]
- C1550600
- UMLS CUI [2,1]
- C0020517
- UMLS CUI [2,2]
- C2825028
- UMLS CUI [2,3]
- C1550600
- UMLS CUI [3]
- C0013182
Description
Animal Insulin | Insulin Glargine Biosimilar
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0003062
- UMLS CUI [1,2]
- C0021641
- UMLS CUI [2,1]
- C0907402
- UMLS CUI [2,2]
- C4045974
Description
Immunomodulatory therapy Regular
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1963758
- UMLS CUI [1,2]
- C0205272
Description
Episode Quantity Hypoglycemia Severe | Loss of hypoglycemic warning
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0332189
- UMLS CUI [1,2]
- C1265611
- UMLS CUI [1,3]
- C0020615
- UMLS CUI [1,4]
- C0205082
- UMLS CUI [2]
- C0342317
Description
Episode of Diabetic Ketoacidosis | Emergency visit Uncontrolled diabetes mellitus | Hospitalization Due to Uncontrolled diabetes mellitus
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0332189
- UMLS CUI [1,2]
- C0011880
- UMLS CUI [2,1]
- C0553618
- UMLS CUI [2,2]
- C0421258
- UMLS CUI [3,1]
- C0019993
- UMLS CUI [3,2]
- C0678226
- UMLS CUI [3,3]
- C0421258
Description
HIV Seropositivity | Hepatitis B antibody positive | Hepatitis B surface antigen positive | Hepatitis C antibody positive
Data type
boolean
Alias
- UMLS CUI [1]
- C0019699
- UMLS CUI [2]
- C0860013
- UMLS CUI [3]
- C0149709
- UMLS CUI [4]
- C0281863
Description
Substance Dependence | Substance Use Disorders
Data type
boolean
Alias
- UMLS CUI [1]
- C0038580
- UMLS CUI [2]
- C0038586
Similar models
Eligibility Type 1 Diabetes NCT02227862
- StudyEvent: Eligibility
C0021641 (UMLS CUI [1,2])
C1550600 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C2825028 (UMLS CUI [2,2])
C1550600 (UMLS CUI [2,3])
C0013182 (UMLS CUI [3])
C0021641 (UMLS CUI [1,2])
C0907402 (UMLS CUI [2,1])
C4045974 (UMLS CUI [2,2])
C0205272 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
C0020615 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,4])
C0342317 (UMLS CUI [2])
C0011880 (UMLS CUI [1,2])
C0553618 (UMLS CUI [2,1])
C0421258 (UMLS CUI [2,2])
C0019993 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C0421258 (UMLS CUI [3,3])
C0860013 (UMLS CUI [2])
C0149709 (UMLS CUI [3])
C0281863 (UMLS CUI [4])
C0038586 (UMLS CUI [2])